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Abstract
Aim: Menopause is a term used to describe the permanent cessation of the primary functions of the human 
ovaries. Menopause typically occurs in women in midlife and signals the end of the fertile phase of a woman’s life. The 
transition from reproductive to non-reproductive is the result of a major reduction in female hormonal production by the 
ovaries. During the menopause remarkable changes happen in the mouth cavity as osteoporosis, periodontal disease, 
Burning Mouth Syndrome (BMS) and xerostomia.
The aim of this work is to describe the changes that occur during the menopause in the mouth cavity and the 
preventive protocols used in the Preventive Dental Department of the University of Milan.
Material and Methods: A systematic literature review about the menopause and its modifications in the mouth 
cavity have been made using the data base Medline and key words as “oral health” and “menopause” have been 
searched.
Discussion and Conclusions: Different changes in women oral condition can be observed during menopause. 
These pathological conditions are typical of the hormonal phase and they must be known by clinicians in order to make 
a correct intervention. Problems as osteoporosis, periodontal disease, Burning mouth syndrome and xerostomia could 
be prevented using specific protocols.
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Introduction
The “menopause” term derives from the Greek words “μήνμηνός” 
(month) and “παὒσις” (cessation). 
Scientifically the menopause is the physiological event that in the 
woman corresponds to the end of the menstrual cycle during the fertile 
age. In the menopause the ovarian activity finishes: the ovaries do not 
produce follicles and estrogens (main female hormones). 
Generally speaking the term indicates only a remarkable loss of 
fluids, coinciding with the period of female climacteric [1].
The terms menopause and climacteric often are used wrongly as 
synonyms; climacteric is a period of transaction during which the 
function of the ovaries stops. In the women this state causes a series of 
changes as metabolic, sexual and psychological aspects, with a series of 
manifestations (symptoms) that are different from person to person. 
These symptoms can be more or less marked, but some of them are not 
connected to the menopause itself: other factors like familiar or social 
contest may influence them [2].
During the menopause remarkable changes happen in several 
districts of human body – as vascular, bone or adipose sections. They 
are often associated to an increased risk of insorgence of pathologies. 
In fact during the menopause the cardiovascular risk - as increment 
of the incidence of myocardial ischaemia and Myocardial infarction, 
ischemic stroke, artery periferic disease - is great as the risk of fractures 
caused by osteoporosis and disorders of the reproductive system.
The aim of this work is to describe the changes that occur during 
the menopause in the mouth cavity and the preventive measures used 
in the School of Milan.
Materials and Methods 
A systematic literature review about the menopause and its 
modifications in the mouth cavity have been made using the data base 
Medline [www.ncbi.nlm.nih.gov/pubmed].
The key words have been “oral health and menopause”. 
The range of articles has been selected from 1980 to 2011.
Only the reported articles to “Humans” have been considered 
using the options of the limits.
Articles published on not indexed reviews and some considerations 
drawn from inherent researches have been then added to. Furthermore 
some preventive protocols used in the School of Milan have been 
introduced. 
Results
Modifications of the mouth cavity during the menopause
The period of the menopause is characterized by important 
physiological changes in the woman body, connected mainly with the 
reduced estrogen production. The consequences of such hormonal 
deficiency are marked in the cases of premature menopause, especially 
if corrected substitutive hormonal therapies have not been established. 
Some meaningful changes regard the mouth cavity as diffused pains, 
gums inflammation, burning, altered modulation of the four main 
tastes (sweet, salt, bitter and acid), dry mouth, loss of teeth and 
resorption of alveolar bone. The hormonal and microbiological 
variations influence also the mouth. A reduction of salivary secretions, 
dryness and irritation of the mucosae and the gums could create a 
gingivo-stomatitis from menopause. 
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However the woman enters in a new season of the life that brings to 
the seniority. It increases the tendency to the osteoporosis that influences 
directly the resorption of the alveolar bone. From an epidemiologic 
point of view, there’s a remarkable increasing of periodontal disease 
connected with age progression in particular the advanced medium 
form. From a therapeutic point of view, it is necessary to act with 
greater determination in order to eliminate not only the inflammation, 
but also the consequences of periodontal disease.
The main pathological oral conditions that can be manifested in 
menopause are: 
• Osteoporosis 
• Periodontal desease (Periodontitis, gingivitis, desquamative 
gingivitis) 
• Burning mouth syndrome (BMS)
• Xerostomia
Osteoporosis: Osteoporosis is a disease characterized by a low 
content of calcium in bones with a resulting weakness of the skeleton 
and the predisposition to the fractures [3]. The relation between 
menopause and osteoporosis is well known: the estrogens take part in 
the regulation of the amount of bone calcium: the decreasing in their 
control, causes the reduction of the calcium level, leaving a porous and 
fragile structure [4,5]. 
Even if the osteoporosis’ mechanisms are not completely clear, 
it is believed that the estrogens promote the cellular programmed 
dead of the osteoclasts and therefore reduce their period of activity. 
The treatment with estrogens or other agents is necessary to prevent 
the bone loss through the block of the production of cytokines in 
osteoblasts and to promote osteoclasts .apoptosis Besides the deficiency 
of estrogens, there are other risk factors able to develop osteoporosis: 
in particular physical inactivity, diet with low level of calcium, 
constitutional thinness, long periods without menstruations, smoking, 
alcool, treatments with cortisonic drugs and genetical predisposition. 
The teeth are based into bone structures. The deterioration, 
inevitable in the old persons, lead to a weakening of their anchorage. 
This makes easier the infiltrations in the periodontal structures that 
becomes more susceptible to the bacterial attack, causing gum disease 
[6,7].
A 30 % of women aged more than 60 are affected by post-
menopause osteoporosis. An alteration of the equilibrium between 
calcium and phosphate produced by a low calcium resorption with diet 
and an increased calcium excretion produced by low levels of estrogens 
can explain some changes of bone level observed in the women during 
postmenopause. This involves the inferior more than the upper jaw and 
interests also the ossification of cartilage of the mandibularcondyloid 
process [8,9].
Periodontitis: Periodontitis is a chronic inflammatory disease 
characterized by gum inflammation and alveolar bone resorption. 
Theperiodontal ligament located between alveolar bone and cement 
has an important role in maintaining the correct periodontal balance 
[10].
Osteoporosis is considered one of the risk factors for the periodontal 
disease and the loss of the teeth. Clinical observations in the women 
in post-menopause have confirmed an increase of the prevalence of 
the periodontal disease, with levels of estrogens more low, even if oral 
hygiene remains unchanged [11].
Gingivitis: Gingivitis is a gum inflammation, characterized by 
swelling, reddening, heating and bleeding derived from an increasing 
of plaque. This disease is reversible after removal of the responsible 
causes. Also some hormones can cause and increase the gingivitis. 
Scientific tests have demonstrated the importance of the so-called 
sexual hormones levels (androgens, estrogens, progestagens). There 
are typical gingivitis during the puberty, pregnancy and menopause: 
gingival inflammation can cause the insurance of a soft tissue hyperplasia 
called “epulide”. Related with the different body modifications caused 
by menopause, is not surprising that 75% of the women over the 35 
years accuse gingival bleeding and symptoms of gum disease. The oral 
symptomatology during the menopause and perimenopause includes 
flush or swelling up of the gums, pain, uneasiness, bleeding, dryness 
and change in the sense of the taste. The first step in order to prevent 
gingival disease and bleeding is to maintain under control the bacteria 
with a correct oral hygiene [12,13].
Desquamative gingivitis: Desquamative gingivitis is not a 
single and defined disease, but it’s also characterized from erythema, 
erosion, bubbles and desquamation of the free and supporter gum. It 
is characterized from red dark gingival tissue, pain and bleeding. The 
desquamation can be preceded from the formation of little blister. 
The gums are soft because the keratinocytes resistant to the food 
particles abrasion are absent. This condition is often present during the 
menopause: the consequelsomministration of progestogen estrogens 
can be effective. A similar gingival lesion can be due topemphigus 
vulgaris, Bullous pemphigoid, non lesivemucous pemphigoidor 
atrophic lichen plants and answers to the therapy with corticosteroids 
[14].
Burning mouth syndrome (BMS): Burning mouth syndrome is 
a typical disease of the feminine sex in particular in the menopause 
period. The main characteristic of the patients with BMS is the oral 
burning diffused in absence of other lesions mucosae and often is 
accompanied from other oral symptoms as xerostomia and dysgeusia. 
Tongue (in particular the back and the tip), palate, lips, superficial tissue 
in relationship with prosthesis and mouth’ floor are involved. In a lot of 
cases burning is due to all the oral tissue. The symptomatology can be 
unexpected or gradual. For definition BMS remains a clinical condition 
in which is not possible to identify the causes certainly and therefore 
the aetiology remains idiopathic. In the clinical practice there are cases 
of oral burning in which it is possible to go back to well known causes, 
but even cases in which no factors can be identified. For this reasons 
it is useful to distinguish the idiopathic BMS from secondary BMS in 
which the therapeutic approach can be guided from the identification 
of the causes.
BMS frequently can be observed in combination with 
psychosomatic disorders. These patients have an expectant personality, 
introvert tending to the depression, to hypochondriasis and to stress. 
These personality disorders can be found in patients during menopause 
and can made worse by the perception of loosing feminine identity. 
Therefore the connection with the estrogenic deficit has been studied 
over a long time. An association between alterations of estrogenic 
hormones, altered function of the salivary glands with qualitative 
and quantitative modifications of salted and presence of oral burning 
has been observed in some patients. Between the causes of secondary 
BMS, local factors as immune system diseases, infections, xerostomia, 
Migratory glossitis and others can be reported. A specific and resolute 
treatment of BMS does not exist. Many drugs have been empirically 
employed in the treatment of the BMS with variable results. The local 
antihistaminics and anaesthetics can be used to calm the burning at least 
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temporary. The administration somministrazione of drugs as placebo 
it sometimes Useful. In the psychosomatic forms, the patient approach 
will have to be of psychological type before still pharmacologic one.
Xerostomia: Xerostomia is a pathological condition with 
insufficient and altered salivary secretion. It is diffused particularly in 
the old persons, expecially women and the incidence is approximately 
a quarter of the general population.
Xerostomia can be permanent or temporary. The salivary 
production returns normal for a temporary period in the diseases with 
high fever and dryness or liquids loss – as diabetes or hyperthyroidism. 
The more important causes of permanent xerostomia are the 
following ones:
• x-rays of neck and head in the treatment of tumors.
• surgical removal of the salivary glands. 
• Sjogren’s syndrome (it is an autoimmune disease that causes a 
destruction of salivary and lacrimal glands) [15].
• xerostomia caused by drugs [16].
Mycoticnfections, dental caries, prosthetic problems and difficulty 
to feed itself can be associated to the xerostomia. Moreover salivary 
reduction involves the presence of a thick plaque and an increasing 
of detritus that can cause periodontal infections. The treatment of 
xerostomia happens is pilocarpina’s administration that increases the 
salivary production.It can be improvedby topical application of salivary 
substitutes even if they do not have a large efficiency.
Saliva: The estrogens have got a regulation role of qualityand 
quantity of salivary secretion [17].
Salivary reduction connected with an estrogen reduction, is a factor 
that compromises dental prostheses adhesion, reducing the possibility 
to chew, to taste the food and to facilitate the digestion.
This condition essentially achieves also an alteration of phonesis 
and mouth confort, feeling known as “dry mouth”. It is clinically 
defined as “xerostomia” and it is due to a reduction of salivary secretion. 
The parameters considered important to know salivary imbalances 
in menopause are:




Cortisol is a steroidhormone produced by adrenal glands and 
derived from cortisone. In particular it belongs to the category of 
glucocorticoid , of which ago part also corticosterone (the less assets). 
Because of endocrine glands’ Atrophy during the aging, the majority of 
hormones produced in smaller amounts/in less uqantity. However the 
levels of cortisol approximately remain constant or decrease in lower 
level (approximately a 15-25% in less regarding the juvenile values). 
Progesterone is important for the good course of the pregnancy. 
Beyond the fifty years progesterone becames important for the woman: 
in fact a too much low level of progesterone increases menopause’s 
disorders.. 
Estradiol is the main estrogenic hormone produced by the ovaries 
during the cycle and it is synthetized from the teca cells of ovary, 
from the testicle and in minimal part from the surrenalic cortex. 
Evaluation of plasmatic levels of this hormone represents an index of 
ovarian functionality and the axis hipothalamus-hipophiisis-gonads. 
Estradiol’s levels are different according to the menstrual cycle: during 
menopause the normal value comes down to 5-27 ng/dl. 
Estriol is one of several conjugated estrogens that can be used 
against the menopause’s symptoms; It is considered a weak estrogen 
regarding estradiol and ethinylestradiol [18].
Different clinical tests have drawned attention to estriol as useful 
support during the menopause. Its effects are:
• it alleviates the symptoms of the menopause (Hot flashes and 
insomnia); 
• it prevents the loss of bone density; 
• it reduces the vaginal dryness and it promotes the health of 
the urinay system in the women in menopause and post 
menopause. 
Rules for Correct Nourishment
A correct nourishment is important also in menopause. In fact it 
prevents the possibility of a weight increase or obesity and provides 
the specific necessities (as an increase of calcium or folates) [19]. 
Osteoporosis starting in menopause can be controlled with a correct 
intervention on nourishment with a good contribution of calcium and 
vitamin D improving the effects of drugs therapy [20]. This can limit 
the use of nutritional supplements in menopause [21].
Preventive Protocols 
Hormonal alterations of woman body make easier problems as 
gum disease and tooth decay. A greater attention is necessary in oral 
hygiene with frequent controls 9. Hormonal increase in the menstrual 
phase causes a greater reactivity of the gums regarding the plaque. 
During the pregnancy the 60-75% of women is subjected to pregnancy 
gingivitis, characterized from reddening, edema and bleeding. Also the 
menopause, that it is characterized by a reduced estrogen production, 
has different conseguences on the mouth cavity: gums inflammation, 
altered modulation of the four main tastes (sweet, salt, bitter and 
acid) and dry mouth. Prevention of periodontal infections may been 
explained carefully, emphasizing the reasons of a frequent Calculus 
buildup removal in addition to a meticulous every day hygiene. Regular 
cleaning visits should be made two times at least in year while in cases 
of bleeding, halitosis or gum inflammation, a dental visit becomes 
obligatory. Furthermore twice daily toothbrushing and flossingmust 
be daily after every meal. The substitutive hormonal therapy can 
be effective also to prevent oral pathologies, but it can have contra 
indication [22,23].
In literature the term Hormone Replacement Therapy (HRT) 
indicates the administration of estrogens by themselves or in 
combination with progesterone ones in women in postmenopause, 
given in order to compensate the following estrogenic deficiency 
during to the cessation of the ovarian production. The association of 
progesterone is justified only in patients with uterus for endometrial 
protection. For the patients who use only estrogenic hormone (without 
uterus) this therapy is known as Estrogen Replacement Therapy (ERT). 
During the patient‘s, it’s not useful to underline the specific connection 
between oral condition and menopause because the patient could have 
the tendency to overstimate this connection and to understimate the 
necessity of measures of individual care. Because of the importance 
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of local factors, the attention goes addressed towards the necessity 
of regular professional interventions and towards the increase of 
the efforts for the everyday plaque control [24-26]. The symptoms 
of physical and emotional changes must be considered during the 
appointments’ development. Probably the patient could be stiff and 
irritable: 
• The relationship between patient and clinician should be 
established with courtesy and personal attention.
• It is important to give attention to the details – in particular 
waiting without reason and using instruments without 
efficiency or calm is not recommended. 
• Boring patient during the conversation is not useful. 
Oral health preservation is particularly important to maintain 
natural teeth. Teeth extraction should be limited in order to avoid 
prosthetic solutions [27,28].
Discussions and Conclusions
During menopause and following periods, different changes in 
women oral condition can be observed. These pathological conditions 
are typical of the hormonal phase that interests all the woman body 
and they must be known by clinicians in order to make a correct 
intervention. Problems as osteoporosis, periodontal disease, Burning 
mouth syndrome and xerostomia could be prevented using specific 
protocols. 
Periodontal tissue is influenced by hormonal action. A rigid 
prevention must be applied to minimize inflammatory problems, 
gingival and mucosal infection and risk of teeth loss.
Patients with removable prosthesis should be subjected to periodic 
hygienic control to prevent the possible lesions that could be found on 
soft oral tissue. Clinician may know the possible hormonal therapies 
and all the drugs’ problems that could be present in the mouth cavity 
during the therapy as xerostomia. 
This work presents the preventive measures used in the School of 
Dentistry of Milan. In particular the correct psychological approach to 
patients during the menopause, the development of hygienic protocols 
during professional appointments and the importance of every day 
plaque control are recommended. For these reasons other studies are 
necessary because of a new attention that menopause needs from a 
social and psychological point of view.
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